Aim: Growth hormone deficiency is a major long-term side effect of therapy in children with medulloblastoma. The aim of our analysis was to find out if growth hormone therapy is as effective in children after medulloblastoma therapy as in children treated for idiopathic growth hormone deficiency.  
